INCON Co. Ltd. 13D and 13G filings for ZyVersa Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-19 06:19 am Sale | 2023-12-31 | 13G | ZyVersa Therapeutics, Inc. ZVSA | INCON Co. Ltd. | 4,278 3.440% | -1,288 (-23.14%) | Filing |
| 2023-02-14 06:05 am Purchase | 2022-12-31 | 13G | ZyVersa Therapeutics, Inc. ZVSA | INCON Co. Ltd. | 5,565 16.490% | 5,565 (New Position) | Filing |